- Home
- SNES vs AIMD Comparison
SNES vs AIMD Comparison
Compare SNES & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNES | AIMD |
|---|---|---|
| Founded | 2004 | 1984 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1M | 9.8M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SNES | AIMD |
|---|---|---|
| Price | $1.76 | $1.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 45.9K | 25.9K |
| Earning Date | 03-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $600,000.00 | N/A |
| Revenue This Year | $29.00 | N/A |
| Revenue Next Year | $95.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 132.56 | N/A |
| 52 Week Low | $1.30 | $0.44 |
| 52 Week High | $5.99 | $4.50 |
Technical Indicators
Market Signals| Indicator | SNES | AIMD |
|---|---|---|
| Relative Strength Index (RSI) | 40.82 | 44.96 |
| Support Level | $1.67 | $1.33 |
| Resistance Level | $2.26 | $1.73 |
| Average True Range (ATR) | 0.18 | 0.12 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 5.00 | 31.43 |
Price Performance
Historical ComparisonAbout SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
About AIMD Ainos Inc.
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.